HSV-2 suppression reduces HIV and HSV shedding.
Collins
Simon
S
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D005260:Female; D015497:HIV-1 / Q000502:physiology*; D006558:Herpes Genitalis / Q000188:drug therapy*; D018258:Herpesvirus 2, Human / Q000502:physiology*; D006801:Humans; D010919:Placebos; D012367:RNA, Viral / Q000097:blood; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017201:Virus Shedding
D000998:Antiviral Agents; D010919:Placebos; D012367:RNA, Viral; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir